AAAAAA

   
Results: 1-5 |
Results: 5

Authors: Walker, K Bowes, M Panesar, M Davis, A Gentry, C Kesingland, A Gasparini, F Spooren, W Stoehr, N Pagano, A Flor, PJ Vranesic, I Lingenhoehl, K Johnson, EC Varney, M Urban, L Kuhn, R
Citation: K. Walker et al., Metabotropic glutamate receptor subtype 5 (mGlu5) and nociceptive functionI. Selective blockade of mGlu5 receptors in models of acute, persistent and chronic pain, NEUROPHARM, 40(1), 2001, pp. 1-9

Authors: Ott, D Floersheim, P Inderbitzin, W Stoehr, N Francotte, E Lecis, G Richert, P Rihs, G Flor, PJ Kuhn, R Gasparini, F
Citation: D. Ott et al., Chiral resolution, pharmacological characterization, and receptor docking of the noncompetitive mGlu1 receptor antagonist (+/-)-2-hydroxyimino-1a,2-dihydro-1H-7-oxacyclopropa[b]naphthalene-7a-carboxylic acid ethyl ester, J MED CHEM, 43(23), 2000, pp. 4428-4436

Authors: Pagano, A Ruegg, D Litschig, S Stoehr, N Stierlin, C Heinrich, M Floersheim, P Prezeau, L Carroll, F Pin, JP Cambria, A Vranesic, I Flor, PJ Gasparini, F Kuhn, R
Citation: A. Pagano et al., The non-competitive antagonists 2-methyl-6-(phenylethynyl)pyridine and 7-hydroxyiminocyclopropan [b]chromen-1 alpha-carboxylic acid ethyl ester interact with overlapping binding pockets in the transmembrane region of group Imetabotropic glutamate receptors, J BIOL CHEM, 275(43), 2000, pp. 33750-33758

Authors: Gasparini, F Lingenhohl, K Stoehr, N Flor, PJ Heinrich, M Vranesic, I Biollaz, M Allgeier, H Heckendorn, R Urwyler, S Varney, MA Johnson, EC Hess, SD Rao, SP Sacaan, AI Santori, EM Velicelebi, G Kuhn, R
Citation: F. Gasparini et al., 2-methyl-6-(phenylethynyl)-pyridine (MPEP), a potent, selective and systemically active mGlu5 receptor antagonist, NEUROPHARM, 38(10), 1999, pp. 1493-1503

Authors: Litschig, S Gasparini, F Rueegg, D Stoehr, N Flor, PJ Vranesic, I Prezeau, L Pin, JP Thomsen, C Kuhn, R
Citation: S. Litschig et al., CPCCOEt, a noncompetitive metabotropic glutamate receptor 1 antagonist, inhibits receptor signaling without affecting glutamate binding, MOLEC PHARM, 55(3), 1999, pp. 453-461
Risultati: 1-5 |